Peru’s President Pedro Castillo receives China’s Sinopharm COVID-19 vaccine

 Peru’s President Pedro Castillo on Friday expressed confidence in China’s Sinopharm COVID-19 vaccine after receiving his dose.

Castillo’s vaccination coincided with the beginning of the mass application of the Sinopharm vaccine to the general population. As of August 6, more than 5.75 million people had completed two doses.

Today Peru has one of the lowest vaccine rates in Latin America and also has its own Covid variant SARS-CoV-2 Lambda. also known as lineage C.37, is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in Peru in December 2020.

According to reports, Genomic sequencing has identified 1,060 cases of Covid-19 caused by the Lambda variant in the United States so far. Japan also confirmed its first case of lambda variant infection this week.

Compared with the conventional strain, the variant may be more infectious and have stronger resistance to vaccines, but its details are not known, the institute said. [jp]

Similar Articles


Most Popular